Prolonged-Release Buprenorphine Therapy in Opioid Use Disorder Can Address Stigma and Improve Patient Quality of Life

Treatment for opioid use disorder (OUD) including opioid agonist therapy (OAT) is effective. Medication with the oral administration of methadone and buprenorphine has well-known limitations (establishing consistent optimal dosing levels, misuse, diversion, and accidental exposure). Treatment may re...

Descripción completa

Detalles Bibliográficos
Autores principales: Somaini, Lorenzo, Vecchio, Sarah, Corte, Camilla, Coppola, Carmen, Mahony, Aisling, Pitts, Alexandra, Cutuli, Manuela, Orso, Rosetta, Littlewood, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568308/
https://www.ncbi.nlm.nih.gov/pubmed/34754672
http://dx.doi.org/10.7759/cureus.18513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568308/
https://www.ncbi.nlm.nih.gov/pubmed/34754672
http://dx.doi.org/10.7759/cureus.18513

Ejemplares similares